Yu Chen Jiao
Direttore Tecnico/Scientifico/R&S presso GENETRON HOLDINGS LIMITED
Posizioni attive di Yu Chen Jiao
Società | Posizione | Inizio | Fine |
---|---|---|---|
GENETRON HOLDINGS LIMITED | Direttore Tecnico/Scientifico/R&S | 01/08/2017 | - |
Beijing Genetron Health Gene Technology Co., Ltd.
Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | - | - |
Chinese Academy of Medical Sciences | Corporate Officer/Principal | 01/12/2013 | - |
Storia della carriera di Yu Chen Jiao
Formazione di Yu Chen Jiao
Peking Union Medical College | Doctorate Degree |
The Johns Hopkins University | Doctorate Degree |
Statistiche
Distribuzione geografica
Cina | 4 |
Isole Cayman | 2 |
Stati Uniti | 2 |
Posizioni
Doctorate Degree | 2 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Consumer Services | 4 |
Technology Services | 2 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Beijing Genetron Health Gene Technology Co., Ltd.
Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China. | Technology Services |
Genetron Holdings Ltd.
Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. | Health Services |
- Borsa valori
- Insiders
- Yu Chen Jiao
- Esperienza